Edwards Larry Todd (CIK 1994805) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy ARQT (30,000 shares), Sell ARQT (3,584 shares), Sell ARQT (103 shares), Sell ARQT (2,052 shares), Sell ARQT (29,131 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Buy | 30,000 | $0 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 3,584 | $90,173 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 103 | $2,669 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 2,052 | $52,326 |
| 2025-11-10 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 29,131 | $732,936 |
| 2025-10-06 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 4,207 | $84,098 |
| 2025-10-06 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 297 | $6,172 |
| 2025-05-20 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 7,451 | $104,836 |
| 2025-03-04 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Buy | 38,000 | $0 |
| 2025-03-04 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Buy | 17,000 | $0 |
| 2025-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | See Remarks | Sell | 2,173 | $27,597 |
Source: SEC Form 4 filings · as of 2026-03-03